IP Australia sits US exams
25 July, 2008 by Staff WritersIP Australia named as search and examination authority for US patent office
Flu's up for Rockeby
24 July, 2008 by Dylan Bushell-EmblingRockeby receives $252,000 worth of orders for bird flu test
Eye and ear on bionics
24 July, 2008 by Kate McDonaldCentre for bionics for NSW, international conference for Victoria
More for AtCor
24 July, 2008 by Dylan Bushell-EmblingAtCor wins two more supply contracts for SphygmoCor, worth $1.66M
GTG responds to BRCA row
24 July, 2008 by Dylan Bushell-EmblingGenetic Technologies responds to criticism over patent enforcement decision
Freeze my puppies
23 July, 2008 by Dylan Bushell-EmblingGenetic Technologies acquires Frozen Puppies Dot Com
Anadis begins trials for IBD
23 July, 2008 by Dylan Bushell-Embling and Kate McDonaldIsraeli trial due for completion in 2009, commercialisation as nutritional to follow
Progen abandons PI-88
23 July, 2008 by Dylan Bushell-Embling and Kate McDonaldMassive share price plunge as Progen abandons lead compound trial
Pfizer Fellowships close soon
23 July, 2008 by Staff WritersApplications for the Pfizer Australia Research Fellowships close on Monday
Biotech summit approaches
23 July, 2008 by Staff WritersThe annual Australian Biotechnology Summit begins next week
Smooth sailing for NeuroDiscovery
22 July, 2008 by Staff WritersPhase I trial of neuropathic pain candidate successful
$45 billion for Genentech
22 July, 2008 by Kate McDonaldRoche offers to buy out remaining Genentech shares for A$45 billion
Biota and GSK kiss and make up
21 July, 2008 by Kate McDonaldMediation and $20 million allows Biota and GSK to conclude litigation over Relenza
Deloitte finalises Recom buy
18 July, 2008 by Kate McDonaldDeloitte completes acquisition of Recombinant Capital
Virosome studied by MedImmune
18 July, 2008 by Dylan Bushell-EmblingNorwood Abbey subsidiary's technology to be evaluated by MedImmune
